<DOC>
	<DOCNO>NCT02055352</DOCNO>
	<brief_summary>To demonstrate free combination budesonide indacaterol efficacious fluticasone salmeterol patient COPD</brief_summary>
	<brief_title>Study Evaluate Efficacy/Safety Combination Budesonide/Indacaterol v Fluticasone/Salmeterol Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone Propionate , Salmeterol Xinafoate Drug Combination</mesh_term>
	<criteria>Written informed consent must obtain assessment perform Outpatients stable COPD group C D accord 2011 GOLD Guidelines . Current exsmokers smoke history least 10 pack year Patients history least one exacerbation . Patients able read complete Use investigational drug within 30 day Patients history hypersensitivity study drug History current diagnosis ECG abnormalities Patients diabetes Type I uncontrolled diabetes Type II include patient history blood glucose level consistently outside normal range Patients achieve acceptable spirometry result Visit 1 Patients body mass index ( BMI ) 40 kg/m2 Patients lung cancer history lung cancer Patients history malignancy organ system Pregnant nursing ( lactate ) woman Women childbearing potential , defined woman physiologically capable become pregnant , unless use effective method contraception dose study treatment Patients maintain regular day/night , waking/sleeping cycle ( e.g. , night shift worker ) Patients uncontrolled unstable permit therapy , opinion investigator , clinically significant renal , cardiovascular , neurological , endocrine , immunological , psychiatric , gastrointestinal , hepatic , haematological abnormality could interfere assessment efficacy safety study treatment Patients require oxygen therapy chronic hypoxemia Patients respiratory tract infection within 6 week prior Visit 1 Patients concomitant pulmonary disease , e.g . pulmonary tuberculosis , bronchiectasis , sarcoidosis , interstitial lung disorder pulmonary hypertension Patients know diagnosis Alpha1 Antitrypsin deficiency . Patients history lung surgery Patients participate active phase supervise pulmonary rehabilitation program . Patients history asthma Other protocoldefined inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>